What Is Transitional Cell Cancer? (2024)

Transitional cells are in your urinary system. It’s the part of your body that includes the kidneys, the bladder and the tubes that connect them. These cells are able to change shape and stretch without breaking and are found throughout your urinary tract. This lets the system expand to store urine and allow it to move through your body.

Transitional cell cancer (TCC) affects these cells. It can be found in the:

  • Renal pelvis (located in the middle of your kidney)
  • Bladder
  • Top part of the ureter -- the long tube that connects your kidneys to your bladder.

The kidneys collect urine in the renal pelvis and then drain it through the ureter into the bladder. From there, it exits your body through your urethra (where you pee).

Types of Transitional Cell Cancer

Transitional cell cancer of the kidney is rare. But the type of TCC that occurs in the bladder -- transitional cell carcinoma -- is the most common kind of bladder cancer.

Transitional cell carcinoma can be either low grade or high grade. If it’s low grade, it isn’t likely to spread into deeper layers of your bladder or anywhere else in your body. It’s also less likely to come back after treatment.

If it’s high grade, it’s more likely to spread to deeper layers of your bladder, other areas of your body, and your lymph nodes. It’s also likely to come back after treatment. High-grade TCC is the type of bladder cancer that is more likely to be life-threatening.

Because transitional cells line many different parts of your urinary tract system, you can sometimes develop tumors in more than one place. If you have TCC in your bladder, you should also be checked for tumors in other parts of your urinary tract system.

Causes

It’s not certain what causes most transitional cell cancers, but there are certain things that can increase your risk:

  • Misusing pain medications for a long time (including over-the-counter medicines)
  • Being exposed to the types of industrial chemicals and dyes used to make leather products, plastics, textiles, and rubber
  • Smoking cigarettes

Symptoms

If you have TCC, you might not experience signs or symptoms in the early stages. But they’ll develop as the cancer grows. It’s important to see your doctor if you experience:

  • Blood in your urine
  • Urination that’s painful or frequent
  • Back pain that doesn’t go away
  • Extreme fatigue
  • Unexplained weight loss

Tests and Diagnosis

To determine your condition, your doctor may use a number of tests:

  • Physical exam to look for any signs of disease
  • Detailed health history to learn about any past illnesses and your health habits
  • Urinalysis to look for things like sugar, protein, bacteria, or blood
  • Urine cytology test to check your urine sample under a microscope for cancer cells

Procedures for diagnosing TCC include:

  • Ureteroscopy. This is how a doctor can look inside your ureter and renal pelvis for anything that doesn’t look right. They’ll use a ureteroscope -- a long, thin tube with a light on the end -- to look through your urinary system. Tissue samples can be taken during this procedure and checked for signs of disease.
  • CT scan, ultrasound, or MRI. These can provide a detailed picture of what’s happening inside your body and help your doctor diagnose TCC.
  • Biopsy. Your doctor may remove a sample of cells or tissue during surgery to look at it under a microscope.

Treatment

Your treatment depends on your overall health and age, as well as how far your cancer has spread and how fast it’s growing. The earlier your cancer is diagnosed, the easier it will be for your doctors to get it under control and potentially cure it. Most cases of TCC in the renal pelvis and ureter can be cured if they’re found and diagnosed early enough.

Surgery is the standard treatment for this type of cancer. If you need surgery, you may require a nephroureterectomy. That’s the removal of your entire kidney, ureter, and the tissue connecting the ureter to the bladder (the bladder cuff).

If your cancer is superficial, your doctor might be able to do a type of surgery called a segmental resection of the ureter. This means your doctor will remove the part of your ureter where the cancer is, as well as some surrounding healthy tissue too. They will then reattach the ends of your ureter.

There are other types of treatments for TCC of the renal pelvis and ureter that are currently being studied in clinical trials:

  • Fulguration: A tool is used to destroy the cancer with electricity.
  • Segmental resection of the renal pelvis: This removes the renal pelvis where the cancer is but leaves the rest of the kidney in place.
  • Laser surgery: A laser is used to either kill the cancer cells or remove them.
  • Regional chemotherapy and regional biologic therapy: This directly targets the part of the body where the cancer is to either stop the growth of the cells or to boost your body’s natural defenses against them.
What Is Transitional Cell Cancer? (2024)

FAQs

What is transitional cell cancer? ›

Urothelial carcinoma, also known as transitional cell carcinoma (TCC), is by far the most common type of bladder cancer. In fact, if you have bladder cancer it's almost always a urothelial carcinoma. These cancers start in the urothelial cells that line the inside of the bladder.

What is the prognosis for transitional cell cancer? ›

These cancers are curable in more than 90% of patients if they are superficial and confined to the renal pelvis or ureter. Patients with deeply invasive tumors that are confined to the renal pelvis or ureter have a 10% to 15% likelihood of cure.

How fast does transitional cell carcinoma grow? ›

TCC is slow growing and usually has no symptoms in the early stages.

Is transitional cell carcinoma aggressive? ›

Transitional cell carcinoma affects the transitional cells of the urinary system and accounts for an overwhelming majority of bladder cancer diagnoses. This cancer may spread rapidly, affecting other organs and becoming life-threatening in some cases.

Does transitional cell carcinoma spread? ›

Transitional cell carcinoma (TCC) of the bladder commonly metastasizes to the pelvic lymph nodes, lungs, liver, bones, adrenals, or brain.

What is the best treatment for transitional cell carcinoma? ›

The following type of treatment is used:

Most people with transitional cell cancer of the renal pelvis and ureter undergo nephroureterectomy. Segmental resection of the ureter is a surgical procedure to remove the part of the ureter that contains cancer and some of the healthy tissue around it.

Can you survive transitional cell carcinoma? ›

It's helpful to get an early diagnosis of transitional cell cancer of the renal pelvis and ureter because the disease is highly curable when it's treated before it spreads. After treatment, patients should continue to see their doctor regularly to monitor the possible recurrence of the cancer.

What is the life expectancy of a person with TCC? ›

The 5-year OS for all bladder TCC was 27.6%, with a mean survival time of 32.6 months. For NMIBC, the 5-year OS was 53.8% with a mean survival of 54.5 months. For MIBC, the 5-year OS was 19% with a mean survival of 25.4 months.

What is the 5-year survival rate for transitional cell carcinoma? ›

Overall survival and cancer-specific survival

For the entire cohort, there were 986 (51.6%) patients who died and 704 (36.9%) patients who died from primary transitional cell carcinoma of the ureter. The median overall survival (OS) was 46 months, and the 5-year OS rate was 41.8%.

Where is the most common location of transitional cell carcinoma? ›

Location. The bladder is by far the most common site of transitional cell carcinomas, 50 times more common than TCC of the renal pelvis, and 100 times more common than TCC of the ureter 1. Bladder TCCs are the most common tumor of the entire urinary tract.

Where does transitional cell carcinoma come from? ›

Transitional cell carcinomas arise from the transitional epithelium, a tissue lining the inner surface of these hollow organs. When the term "urothelial" is used, it specifically refers to a carcinoma of the urothelium, meaning a transitional cell carcinomas of the urinary system.

Where does transitional cell carcinoma occur? ›

Urothelial carcinoma (also called transitional cell carcinoma) is cancer that begins in the urothelial cells, which line the urethra, bladder, ureters, renal pelvis, and some other organs. Almost all bladder cancers are urothelial carcinomas.

What is the deadliest carcinoma? ›

Lung & Bronchus

Lung and bronchial cancer causes more deaths in the U.S. than any other type of cancer in both men and women. Although survival rates have increased over the years due to improved treatments, the outlook is still bleak.

What is the most aggressive carcinoma? ›

The most aggressive cancers with the shortest life expectancy from diagnosis are pancreatic cancer, lung cancer and hepatocellular carcinoma or liver cancer. In each case, the risk of illness is influenced by lifestyle, especially smoking and heavy alcohol consumption.

Is transitional cell carcinoma benign? ›

Transitional Cell Epithelial Tumors or “Brenner's Tumors”

They may be associated with similar tumors in the urinary bladder and are benign and consist of 1% to 3% of all ovarian tumors.

Is transitional cell cancer curable? ›

It's helpful to get an early diagnosis of transitional cell cancer of the renal pelvis and ureter because the disease is highly curable when it's treated before it spreads. After treatment, patients should continue to see their doctor regularly to monitor the possible recurrence of the cancer.

What is the difference between transitional cell carcinoma and bladder cancer? ›

Urothelial (transitional cell) bladder cancer

About 90 out of 100 bladder cancers in the UK (about 90%) are urothelial cancer. These are also called transitional cell cancer. Urothelial cancer develops from the cells of the bladder lining (urothelium). These are called transitional or urothelial cells.

What is the most aggressive type of bladder cancer? ›

What is the most aggressive form of bladder cancer? In general, bladder cancers that are muscle invasive and/or have high-grade cells are the most serious and aggressive.

Top Articles
Latest Posts
Article information

Author: Van Hayes

Last Updated:

Views: 5880

Rating: 4.6 / 5 (46 voted)

Reviews: 85% of readers found this page helpful

Author information

Name: Van Hayes

Birthday: 1994-06-07

Address: 2004 Kling Rapid, New Destiny, MT 64658-2367

Phone: +512425013758

Job: National Farming Director

Hobby: Reading, Polo, Genealogy, amateur radio, Scouting, Stand-up comedy, Cryptography

Introduction: My name is Van Hayes, I am a thankful, friendly, smiling, calm, powerful, fine, enthusiastic person who loves writing and wants to share my knowledge and understanding with you.